Literature DB >> 431595

Hypothalamic-pituitary-gonadal dysfunction in men using cimetidine.

D H Van Thiel, J S Gavaler, W I Smith, G Paul.   

Abstract

We studied the effect of cimetidine therapy (1200 mg per day by mouth for nine weeks) on the hypothalamic-pituitary-gonadal axis of seven men. There was a 43 per cent mean reduction in sperm count after therapy. The luteinizing hormone response to luteinizing hormone releasing factor was also reduced, and a statistically significnat rise in plasma testosterone occurred, although it was less than that before therapy. Gonadotropin responses to provocative clomiphene stimulation were inadequate when compared with those of controls. Cimetidine did not affect the responses of thyroid-stimulating hormone, prolactin, growth hormone and thyroxine to thyrotropin releasing factor. Caution is advisable in administration of cimetidine for prolonged periods to young men.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 431595     DOI: 10.1056/NEJM197905033001803

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  39 in total

1.  Investigation and management of male infertility.

Authors:  J F Vallely
Journal:  Can Fam Physician       Date:  1983-07       Impact factor: 3.275

2.  Plasma prolactin, sex steroids and gastrin in human volunteers treated for 2 weeks with therapeutic doses of cimetidine or the new histamine H2-receptor antagonist ramixotidine (CM 57755A).

Authors:  M Colle; E Ruedas; J Cazenave; J Auzerie; G Basilisco; G Camboni; L Manara
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Male infertility: diagnosis and treatment.

Authors:  S L Chan
Journal:  Can Fam Physician       Date:  1988-08       Impact factor: 3.275

4.  Plasma concentrations of pituitary and peripheral hormones during ranitidine treatment for two years in men with duodenal ulcer.

Authors:  U Knigge; B Thuesen; A Dejgaard; P Bennett; P M Christiansen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Antiprostatic effect of cimetidine in rats.

Authors:  P Pinelli; S Trivulzio; R Colombo; D Cocchi; R Faravelli; F Caviezel; G Galmozzi; R Cavallaro
Journal:  Agents Actions       Date:  1987-12

Review 6.  Newer antisecretory agents for peptic ulcer.

Authors:  K W Somerville; M J Langman
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

7.  Ranitidine and testosterone secretion in man.

Authors:  V Savarino; M Giusti; C Mansi; M Marugo; G Delitala; G Celle
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

8.  Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients.

Authors:  S J Konturek; W Obtulowicz; N Kwiecien; E Sito; E Mikos; J Oleksy
Journal:  Gut       Date:  1980-03       Impact factor: 23.059

9.  Manuscript requirements: the advance from Vancouver.

Authors:  E Huth
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-03

Review 10.  Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.

Authors:  T Andersson
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.